Early adverse events as predictors of 1-year mortality during mechanical circulatory support
- 30 September 2010
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 29 (9), 981-988
- https://doi.org/10.1016/j.healun.2010.04.014
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Leukocytosis as a predictor for non-infective mortality and morbidityQJM: An International Journal of Medicine, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device ImplantationThe Annals of Thoracic Surgery, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- End-organ Function in Patients on Long-term Circulatory Support With Continuous- or Pulsatile-flow Assist DevicesThe Journal of Heart and Lung Transplantation, 2007
- Predictors and Outcomes of Continuous Veno-venous Hemodialysis Use After Implantation of a Left Ventricular Assist DeviceThe Journal of Heart and Lung Transplantation, 2006
- Obesity, Insulin Resistance, and the Metabolic SyndromeCirculation, 2005
- Left Ventricular Assist Device–Related Infection: Treatment and OutcomeClinical Infectious Diseases, 2005
- Different Profiles of Patients Who Require Dialysis After Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001